SuperworthMedtronic dividend yield MDT
Dividends per share over the last twelve months divided by the share price, since 1982.
- Today, Oct 23, 2026
- 3.00%
- 10-year median
- 2.3%
- Against its 10-year history
- 64th
- percentile: 0 is its lowest day, 100 its highest
- 10-year range
- 1.8% to 3.9%
- Peer median
- 1.1%
Medtronic pays 3.00% of its share price in dividends over a year, as of Oct 23, 2026.
That is above its ten-year median of 2.3%, close to the middle of its last ten years.
Over that time it ranged from 1.8% in Sep 2021 to 3.9% in Oct 2023.
The median for 7 medical device stocks of a similar size is 1.1%.
Dividend yield over time
The dashed line is the 10-year median and the shaded band the middle half of its days.
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 3.0% | 2.7% | 3.8% |
| 2025 | 2.9% | 2.7% | 3.5% |
| 2024 | 3.5% | 3.0% | 3.6% |
| 2023 | 3.3% | 3.0% | 3.9% |
| 2022 | 3.4% | 2.2% | 3.4% |
| 2021 | 2.4% | 1.8% | 2.4% |
| 2020 | 1.9% | 1.8% | 2.7% |
| 2019 | 1.9% | 1.8% | 2.4% |
| 2018 | 2.2% | 1.9% | 2.4% |
| 2017 | 2.2% | 1.9% | 2.3% |
| 2016 | 2.3% | 1.7% | 2.3% |
| 2015 | 1.9% | 1.5% | 2.1% |
| 2014 | 1.6% | 1.6% | 2.0% |
| 2013 | 1.9% | 1.8% | 2.4% |
| 2012 | 2.5% | 2.2% | 2.7% |
| 2011 | 2.4% | 2.1% | 2.9% |
| 2010 | 2.3% | 1.7% | 2.6% |
| 2009 | 1.8% | 1.8% | 2.8% |
| 2008 | 2.0% | 1.0% | 2.1% |
| 2007 | 0.9% | 0.8% | 1.0% |
Against its peers
Companies in Medical - Devices nearest Medtronic's size, closest first, today.
| Company | Dividend yield |
|---|---|
| MDTMedtronic | 3.00% |
| SYKStryker | 1.15% |
| ABTAbbott Laboratories | 2.43% |
| BSXBoston Scientific | n/m |
| EWEdwards Lifesciences | n/m |
| GEHCGE HealthCare Technologies | 0.20% |
| DXCMDexCom | n/m |
| ZBHZimmer Biomet | n/m |
| Peer median | 1.15% |
Where Medtronic ranks
What the dividend yield tells you
Yearly dividends per share divided by the share price.
A yield that suddenly looks high often means the price fell because the dividend is at risk.
More on Medtronic
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.